Skip to main content

Pancreas transplant - the honest route, explained.

For the right person with type 1 diabetes, a pancreas transplant means no insulin at all. In the UK the operation itself runs through NHS transplant centres - organs are allocated nationally - so our job is different: rapid private assessment, an unhurried second opinion, and steering your referral to the right centre without losing months.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What can - and cannot - be paid for privately.

Donor organs in the UK are allocated by NHS Blood and Transplant and cannot be bought.

In short

The transplant itself is NHS-funded. A full private transplant-suitability work-up: £1,500–£3,500, completed in 2–3 weeks.

Service Indicative range
Transplant surgeon or nephrologist consultation £250–£450
Private transplant-suitability work-up (cardiac, vascular, bloods) £1,500–£3,500
Second opinion on listing decision or centre choice £300–£500
Hybrid closed-loop pump set-up while waiting £2,000–£4,000 + consumables
Pancreas transplant operation (SPK, PAK or PTA) NHS-funded
Islet cell transplantation NHS-funded (commissioned centres)

Be wary of overseas packages offering self-pay pancreas transplants at $100,000+ - outcomes depend heavily on centre volume and aftercare, and lifelong immunosuppression still has to be managed at home. The UK route through an NHS centre, accelerated by private assessment, is almost always the safer answer. We tell you plainly if we think otherwise.

The problem

The right operation, the right centre, and a work-up that does not stall.

Pancreas transplant pathways fail patients in predictable ways - referrals to the wrong centre, work-ups that expire before listing, and technology alternatives never properly tried. We fix all three.

  • Could technology do it instead?

    Hybrid closed-loop pumps abolish severe hypos for many people. We make sure that option has been genuinely exhausted before anyone consents to lifelong immunosuppression.

  • Centre choice is outcome choice

    A handful of UK units do this surgery, and volumes differ. We route your referral to the centre whose experience fits your case.

  • A work-up that arrives complete

    Listing meetings defer cases over one missing echo. Our private work-up lands on the MDT table finished - so the decision happens first time.

When it helps

When a pancreas transplant is worth considering.

The situations that lead to transplant assessment, plus the one red flag that needs the emergency department rather than a clinic booking.

  • Type 1 diabetes with kidney failure

    The classic SPK candidate - one operation replaces both organs, and outcomes beat kidney transplant alone in the right person.

  • A kidney transplant already in place

    Pancreas-after-kidney (PAK) adds insulin independence and protects the transplanted kidney from further diabetic damage.

  • Severe hypoglycaemia unawareness

    Recurrent, life-threatening lows with no warning symptoms despite sensors and closed-loop pumps - the main indication for pancreas-alone or islet transplant.

  • Brittle, unmanageable glucose control

    Extreme swings hospitalising you repeatedly despite specialist input and the best technology available.

  • Rapidly progressing diabetic complications

    Advancing retinopathy, neuropathy or early nephropathy where restoring normal glucose could change the trajectory.

  • Technology tried, and not enough

    Listing rightly requires that hybrid closed-loop and structured education have been given a proper trial first. We help arrange exactly that.

  • Type 2 diabetes - occasionally

    A small, carefully selected group of insulin-dependent people with type 2 diabetes and kidney failure are now considered for SPK at some centres.

  • Red flag: severe hypo happening now

    Confusion, seizures or collapse from low glucose is a 999 emergency - glucagon and A&E first. Transplant conversations come later.

Transplant options

Which option fits depends almost entirely on your kidney function and what has already been transplanted.

  • Simultaneous pancreas-kidney (SPK)

    The most common and best-performing option - around three-quarters of UK pancreas transplants. Both organs from the same donor, one operation, one set of immunosuppression.

  • Pancreas after kidney (PAK)

    For those who already have a functioning kidney transplant, often from a living donor. Adds the pancreas at a second operation.

  • Pancreas transplant alone (PTA)

    For life-threatening hypoglycaemia unawareness with preserved kidney function. The immunosuppression trade-off is weighed especially carefully here.

  • Islet cell transplantation

    Donor islets infused into the liver under local anaesthetic - far less invasive, but usually reduces rather than abolishes insulin needs, and often takes two infusions.

  • Enteric vs bladder drainage

    Nearly all UK grafts drain digestive secretions into the bowel (enteric). Bladder drainage is now rare and mostly historical.

  • Systemic venous drainage

    The graft’s insulin drains into the iliac vein in most UK centres - technically simpler, with equivalent long-term outcomes to portal drainage.

  • The alternative: closed-loop technology

    Hybrid closed-loop pumps now deliver excellent control for many people who would once have needed a PTA. We make sure this has been properly explored first.

  • The future: waiting well

    While listed, everything matters - cardiovascular fitness, weight, vaccination status. We keep the work-up current so an organ offer is never missed.

Safety and recovery

Major surgery, honestly weighed.

A pancreas transplant trades daily insulin for lifelong immunosuppression. That trade is worth it for the right person - and wrong for many others. Here is the honest ledger.

  • This is major surgery

    4–6 hours under general anaesthetic, high-dependency care afterwards, and 2–3 weeks in hospital. Fitness for it is exactly what the assessment tests.

  • Graft thrombosis is the early enemy

    Clotting of the graft’s blood vessels affects roughly 5% of pancreas transplants in the first days and usually means losing the graft. Anticoagulation and close monitoring are routine.

  • Bleeding, leaks and re-operation

    Bleeding, enteric anastomotic leak and graft pancreatitis can each require a return to theatre - around 1 in 5 recipients need some form of re-intervention early on.

  • Rejection

    Acute rejection affects roughly 10–20% in the first year and is usually treatable if caught early - which is why the follow-up schedule is so intensive.

  • Immunosuppression, for life

    Tacrolimus-based regimens bring infection risk, kidney strain, tremor and a raised long-term risk of skin cancers and lymphoma. This is the permanent cost of insulin freedom.

  • What you gain

    A functioning graft means normal glucose without insulin, no hypos, stabilisation of many complications - and for SPK recipients, freedom from dialysis. Around 85–90% of grafts work at one year.

  • How long grafts last

    Median pancreas graft survival is well over a decade in the SPK setting. PTA grafts historically fare less well, which shapes the listing conversation.

  • Fertility and life planning

    Pregnancy after transplant is possible but needs planning with the transplant team - immunosuppression must be adjusted in advance.

  • Red flags after transplant

    Fever, pain over the graft, rising glucose, reduced urine output or breathlessness need the transplant unit the same day - every recipient carries a 24-hour contact number.

Reading your transplant summary

Your transplant summary in four parts. Read the last one first.

After assessment - and again after surgery - the centre writes to you and your GP. The letters keep to the same shape.

A UK transplant physician reviewing a patient’s assessment summary

A quiet reminder

Transplant letters are dense with drug levels and acronyms - we translate them for you.

If you would like us to talk you through your assessment outcome, listing decision or immunosuppression plan before your next clinic, just ask.

  1. 01 Header

    Diagnosis, transplant type and listing status

    Which operation is proposed - SPK, PAK, PTA or islet - and where you stand: under assessment, listed, suspended or transplanted.

  2. 02 Work-up

    Cardiac, vascular and immunology results

    The tests that determine fitness: stress testing, iliac vessel imaging, tissue typing and antibody levels that shape how long you may wait.

  3. 03 Findings

    Graft function and drug levels

    After transplant: glucose and C-peptide showing the graft at work, kidney function, and tacrolimus levels with target ranges.

  4. 04 Impression

    The plan, and what to watch for

    Read this first: the next steps, medication changes, and exactly which symptoms should trigger a same-day call to the unit.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

UK private medical insurance does not fund the transplant operation itself - it is NHS-delivered - but many policies cover the private consultations, cardiac work-up and diabetes technology around it.

Frequently asked

Everything we get asked about pancreas transplants.

Quick answers on eligibility, the wait, insulin independence, immunosuppression and what can genuinely be done privately.

  • Can I pay for a pancreas transplant privately in the UK?

    No - donor organs are allocated nationally by NHS Blood and Transplant and cannot be bought, so the operation itself is only performed in NHS transplant centres. What can be done privately is the assessment, imaging and second opinions around it, which often shortens the road to listing considerably.

  • Who qualifies for a pancreas transplant?

    Most UK recipients have type 1 diabetes with kidney failure and receive a simultaneous pancreas-kidney (SPK) transplant. Others qualify after a previous kidney transplant (PAK), or - with preserved kidneys - because of severe, life-threatening hypoglycaemia unawareness that persists despite closed-loop technology (PTA or islet transplant).

  • Will I really come off insulin?

    If the graft functions, yes - usually within days of surgery. Around 85–90% of pancreas grafts are working at one year, and a functioning graft means normal glucose with no injections and no hypos. Islet transplantation more often reduces insulin needs and abolishes severe hypos rather than removing insulin entirely.

  • How long is the wait for a pancreas?

    It varies with blood group, antibody levels and the type of transplant, but most people wait months to a year or more once listed. Highly sensitised patients can wait longer.

  • What is the difference between a pancreas transplant and an islet transplant?

    A pancreas transplant is major surgery implanting the whole organ, with the best chance of full insulin independence. Islet transplantation infuses only the insulin-producing cells into the liver through a small tube - far less invasive, but usually needing two infusions and more often reducing rather than replacing insulin. Both require lifelong immunosuppression.

  • Is the immunosuppression worse than the diabetes?

    That is precisely the question the assessment weighs. For someone with kidney failure who needs immunosuppression for a kidney anyway, adding a pancreas costs little extra. For someone with working kidneys, lifelong tacrolimus is a genuine trade against severe hypoglycaemia - worth it for some, not for others. We help you think it through with no stake in the answer.